BROWN BOB D (Chief Scientific Officer) sold 27.9% of their position (8.31K shares) of DICERNA PHARMACEUTICALS INC on the open market
Open‑market sale worth $310.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2021ACC: 0001399529-21-000135
Officer· Chief Scientific Officer
Since Jan 2019
-8.31K
Net shares
Net seller
$310.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.31K acquired · 16.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.31K
Price / share
$3.42
Trade value
$28.43K
% of position
38.6%
8/2/2021
21.52K→29.83K
Common Stock
Direct
Shares
−8.31K
Price / share
$37.38
Trade value
$310.68K
% of position
27.9%
8/2/2021
29.83K→21.52K
Total
Net shares
+0.00
Net value
-$282.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/2/2021 | M · Option Exercise | +8.31K | $3.42 | $28.43K | 38.6% | 21.52K | 29.83K |
| Common Stock Direct | 8/2/2021 | S · Sale | −8.31K | $37.38 | $310.68K | 27.9% | 29.83K | 21.52K |
| Total | +0.00 | -$282.25K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.31K shares
Shares
−8.31K
Strike price
3.42
Held after
24.94K
Exercisable
—
8/2/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock8.31K shares | 8/2/2021 | M · Option Exercise | −8.31K | 3.42 | — | 24.94K |